Thiazolidinediones, deadly sins, surrogates, and elephants

Lancet. 2007 Sep 29;370(9593):1103-4. doi: 10.1016/S0140-6736(07)61488-3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Clinical Trials as Topic / methods*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Meta-Analysis as Topic
  • Myocardial Infarction / chemically induced*
  • Myocardial Infarction / mortality
  • Risk
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone